Company: ISRG
Filing Date: 2025-01-31
Form Type: 10-K
Source: 0001035267-25-000017
Chunk: 31

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-01-31
Form: 10-K
Item: Item 7
Chunk 31
---
.$5,589.4 $4,688.6 $4,157.6 OUS2,762.7 2,435.5 2,064.6 Total revenue$8,352.1 $7,124.1 $6,222.2 % of Revenue — U.S.67%66%67%% of Revenue — OUS33%34%33%Instruments and accessories$5,079.0 $4,276.6 $3,517.9 Services1,307.1 1,167.8 1,024.2 Operating lease revenue654.2 500.5 376.5 Total recurring revenue$7,040.3 $5,944.9 $4,918.6 % of Total revenue 84%83%79%Da Vinci Surgical System Placements by RegionU.S. unit placements800 666 692 OUS unit placements726 704 572 Total unit placements*1,526 1,370 1,264 *Systems placed under fixed-payment operating lease arrangements (included in total unit placements)309 304 276 *Systems placed under usage-based operating lease arrangements (included in total unit placements)467 355 216 Da Vinci Surgical System Placements involving System Trade-insUnit placements involving trade-ins150 240 345 Unit placements not involving trade-ins1,376 1,130 919 Ion System Placements**271 213 192 **Systems placed under fixed-payment operating lease arrangements (included in total unit placements)85 63 61 **Systems placed under usage-based operating lease arrangements (included in total unit placements)68 54 40 

75

Product Revenue

Product revenue increased by 18% to $7.05 billion for the year ended December 31, 2024, compared to $5.96 billion for the year ended December 31, 2023. Product revenue for the year ended December 31, 2023, increased by 15% compared to $5.20 billion for the year ended December 31, 2022.

Instruments and accessories revenue increased by 19% to $5.08 billion for the year ended December 31, 2024, compared to $4.28 billion for the year ended December 31, 2023. The increase in instruments and accessories revenue was primarily driven by approximately 17% higher